Disruptive AI technology that is leading the future in impairment detection and healthcare screenings

Disruptive technologies for impairment and healthcare

CANNABIS

AND ALCOHOL IMPAIRMENT

Our first-to-market AI product screens for Cannabis impairment and is being expanded to include screening for alcohol and opioids.

INFECTIOUS

DISEASE

We are harnessing our AI technology to be used globally in healthcare, with our primary focus on COVID-19 screenings. PREDICTMEDIX can be deployed in settings outside of hospitals and healthcare facilities or at any location where people gather or where transmission security is paramount.

MENTAL

ILLNESS

Our disruptive technology can detect mental illness at early stages giving healthcare practitioners the opportunity to provide proper care before their patient's condition worsens. Employers can use our technology to protect and care for the mental health of their workforce.

PARTNERSHIPS

171449-500x500.jpg

Ranked among top 15 global IT companies by Forbes. $4.9 billion dollar company owned by Mahindra Group, a $420.7 billion dollar federation of companies.

The worldwide industry leader in aluminium and copper. Hindalco is the metals flagship company of Aditya Birla Group, with a consolidated annual revenue of $18.7 billion.

Globally top ranked engineering school whose alumni include CEO’s and CTO’s of many Fortune 500 companies including Google, IBM and Microsoft.

OUR LATEST NEWS AND UPDATES

77 King st West #3000

Toronto, ON

1 (647) 889-6916

© PredictMedix Inc all rights reserved

LINKS

Sign up for email updates 

  • Twitter
  • LinkedIn
  • Instagram